Main > ONCOLOGY (**) > Prostate Cancer mCRPC BRCAm Treat.>

---

Prostate Cancer mCRPC BRCAm Treat.>'s subsections
(*) EU CE Mark Date: 2022. 12.21
(*) JP Approval Date: 2023. 08.24
(*) USA Approval Date: 2023. 06.01.
>PARP Inhibitor+Abiraterone
Company
Generic Name:
RTM
RTM Web-Site
USA Patent Numbers:

Prostate Cancer mCRPC BRCAm Treat.>'s products
This section has no products